The impact of intracytoplasmic mucin in lung adenocarcinoma with pneumonic radiological presentation.

[1]  W. Travis,et al.  New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  K. Kerr,et al.  Detection of Anaplastic Lymphoma Kinase ( ALK ) Gene Rearrangement in Non-Small Cell Lung Cancer and Related Issues in ALK Inhibitor Therapy A Literature Review , 2012 .

[3]  Takeshi Nagayasu,et al.  Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung. , 2012, The Journal of clinical investigation.

[4]  K. Kerr,et al.  Detection of anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer and related issues in ALK inhibitor therapy: a literature review. , 2012, Molecular diagnosis & therapy.

[5]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  T. Nishimura,et al.  Frequency of EGFR and KRAS Mutations in Japanese Patients with Lung Adenocarcinoma with Features of the Mucinous Subtype of Bronchioloalveolar Carcinoma , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  Ping Yang,et al.  Clinical Features of Bronchioloalveolar Carcinoma with New Histologic and Staging Definitions , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[8]  G. Rossi,et al.  A Single Institution-Based Retrospective Study of Surgically Treated Bronchioloalveolar Adenocarcinoma of the Lung: Clinicopathologic Analysis, Molecular Features, and Possible Pitfalls in Routine Practice , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  M. Antoine,et al.  Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib. , 2010, Lung cancer.

[10]  D. Kufe,et al.  Mucins in cancer: function, prognosis and therapy , 2009, Nature Reviews Cancer.

[11]  Ho Yun Lee,et al.  Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons. , 2009, Lung cancer.

[12]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  A. Iafrate,et al.  Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features. , 2007, The Journal of molecular diagnostics : JMD.

[14]  Y. Miyagi,et al.  Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations. , 2007, American journal of clinical pathology.

[15]  M. Antoine,et al.  Neutrophils Promote Aerogenous Spread of Lung Adenocarcinoma with Bronchioloalveolar Carcinoma Features , 2007, Clinical Cancer Research.

[16]  Y. Ueda,et al.  Bronchioloalveolar carcinoma of mixed mucinous and nonmucinous type: immunohistochemical studies and mutation analysis of the p53 gene. , 2006, Pathology, research and practice.

[17]  F. Hirsch,et al.  The Bronchioloalveolar Carcinoma and Peripheral Adenocarcinoma Spectrum of Diseases , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[18]  J. Nadel,et al.  Neutrophil Elastase Induces MUC5AC Mucin Production in Human Airway Epithelial Cells via a Cascade Involving Protein Kinase C, Reactive Oxygen Species, and TNF-α-Converting Enzyme1 , 2005, The Journal of Immunology.

[19]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[20]  F. Chiarotti,et al.  Comparative analysis of clinical features and prognostic factors in resected bronchioloalveolar carcinoma and adenocarcinoma of the lung. , 2003, Anticancer research.

[21]  B. Milleron,et al.  Clinical characteristics of pneumonic-type adenocarcinoma of the lung. , 2003, Chest.

[22]  B. Milleron,et al.  Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. , 2003, Cancer research.

[23]  B. Milleron,et al.  Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma. , 2001, The American journal of pathology.

[24]  A. Carretta,et al.  Evaluation of radiological and pathological prognostic factors in surgically-treated patients with bronchoalveolar carcinoma. , 2001, European Journal of Cardio-Thoracic Surgery.

[25]  B. Fischer,et al.  Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[26]  N. Santelmo,et al.  Bronchioloalveolar lung carcinoma: results of surgical treatment and prognostic factors. , 1998, Chest.

[27]  B. Gasser,et al.  Bronchoalveolar carcinoma: histopathologic study of evolution in a series of 105 surgically treated patients. , 1998, Chest.

[28]  P. Pairolero,et al.  Bronchoalveolar carcinoma: factors affecting survival. , 1991, The Annals of thoracic surgery.

[29]  D. Garfield,et al.  Bronchioloalveolar carcinoma: the case for two diseases. , 2008, Clinical lung cancer.

[30]  D. Sugarbaker,et al.  Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease. , 2001, The Journal of thoracic and cardiovascular surgery.

[31]  B. Fischer,et al.  Neutrophil elastase increases MUC 5 AC mRNA and protein expression in respiratory epithelial cells , 1999 .

[32]  A. Flahault,et al.  Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. , 1998, The American journal of pathology.

[33]  H. Mori,et al.  Mucin‐producing Tumor of the Lung: CT Findings , 1995, Journal of thoracic imaging.